Cargando…
Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation
The escalating prevalence of Type 2 Diabetes (T2D) represents a substantial burden on global healthcare systems, especially in regions such as Mexico. Existing diagnostic techniques, although effective, often require invasive procedures and labor-intensive efforts. The promise of artificial intellig...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594466/ https://www.ncbi.nlm.nih.gov/pubmed/37873778 http://dx.doi.org/10.3390/diseases11040134 |
_version_ | 1785124656560209920 |
---|---|
author | García-Domínguez, Antonio Galván-Tejada, Carlos E. Magallanes-Quintanar, Rafael Cruz, Miguel Gonzalez-Curiel, Irma Delgado-Contreras, J. Rubén Soto-Murillo, Manuel A. Celaya-Padilla, José M. Galván-Tejada, Jorge I. |
author_facet | García-Domínguez, Antonio Galván-Tejada, Carlos E. Magallanes-Quintanar, Rafael Cruz, Miguel Gonzalez-Curiel, Irma Delgado-Contreras, J. Rubén Soto-Murillo, Manuel A. Celaya-Padilla, José M. Galván-Tejada, Jorge I. |
author_sort | García-Domínguez, Antonio |
collection | PubMed |
description | The escalating prevalence of Type 2 Diabetes (T2D) represents a substantial burden on global healthcare systems, especially in regions such as Mexico. Existing diagnostic techniques, although effective, often require invasive procedures and labor-intensive efforts. The promise of artificial intelligence and data science for streamlining and enhancing T2D diagnosis is well-recognized; however, these advancements are frequently constrained by the limited availability of comprehensive patient datasets. To mitigate this challenge, the present study investigated the efficacy of Generative Adversarial Networks (GANs) for augmenting existing T2D patient data, with a focus on a Mexican cohort. The researchers utilized a dataset of 1019 Mexican nationals, divided into 499 non-diabetic controls and 520 diabetic cases. GANs were applied to create synthetic patient profiles, which were subsequently used to train a Random Forest (RF) classification model. The study’s findings revealed a notable improvement in the model’s diagnostic accuracy, validating the utility of GAN-based data augmentation in a clinical context. The results bear significant implications for enhancing the robustness and reliability of Machine Learning tools in T2D diagnosis and management, offering a pathway toward more timely and effective patient care. |
format | Online Article Text |
id | pubmed-10594466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105944662023-10-25 Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation García-Domínguez, Antonio Galván-Tejada, Carlos E. Magallanes-Quintanar, Rafael Cruz, Miguel Gonzalez-Curiel, Irma Delgado-Contreras, J. Rubén Soto-Murillo, Manuel A. Celaya-Padilla, José M. Galván-Tejada, Jorge I. Diseases Article The escalating prevalence of Type 2 Diabetes (T2D) represents a substantial burden on global healthcare systems, especially in regions such as Mexico. Existing diagnostic techniques, although effective, often require invasive procedures and labor-intensive efforts. The promise of artificial intelligence and data science for streamlining and enhancing T2D diagnosis is well-recognized; however, these advancements are frequently constrained by the limited availability of comprehensive patient datasets. To mitigate this challenge, the present study investigated the efficacy of Generative Adversarial Networks (GANs) for augmenting existing T2D patient data, with a focus on a Mexican cohort. The researchers utilized a dataset of 1019 Mexican nationals, divided into 499 non-diabetic controls and 520 diabetic cases. GANs were applied to create synthetic patient profiles, which were subsequently used to train a Random Forest (RF) classification model. The study’s findings revealed a notable improvement in the model’s diagnostic accuracy, validating the utility of GAN-based data augmentation in a clinical context. The results bear significant implications for enhancing the robustness and reliability of Machine Learning tools in T2D diagnosis and management, offering a pathway toward more timely and effective patient care. MDPI 2023-09-30 /pmc/articles/PMC10594466/ /pubmed/37873778 http://dx.doi.org/10.3390/diseases11040134 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article García-Domínguez, Antonio Galván-Tejada, Carlos E. Magallanes-Quintanar, Rafael Cruz, Miguel Gonzalez-Curiel, Irma Delgado-Contreras, J. Rubén Soto-Murillo, Manuel A. Celaya-Padilla, José M. Galván-Tejada, Jorge I. Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation |
title | Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation |
title_full | Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation |
title_fullStr | Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation |
title_full_unstemmed | Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation |
title_short | Optimizing Clinical Diabetes Diagnosis through Generative Adversarial Networks: Evaluation and Validation |
title_sort | optimizing clinical diabetes diagnosis through generative adversarial networks: evaluation and validation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594466/ https://www.ncbi.nlm.nih.gov/pubmed/37873778 http://dx.doi.org/10.3390/diseases11040134 |
work_keys_str_mv | AT garciadominguezantonio optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT galvantejadacarlose optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT magallanesquintanarrafael optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT cruzmiguel optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT gonzalezcurielirma optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT delgadocontrerasjruben optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT sotomurillomanuela optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT celayapadillajosem optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation AT galvantejadajorgei optimizingclinicaldiabetesdiagnosisthroughgenerativeadversarialnetworksevaluationandvalidation |